$6.75
3.16% today
Nasdaq, May 07, 08:34 pm CET
ISIN
US28531P1030
Symbol
ECOR

electroCore, Inc. Stock price

$6.97
+1.29 22.71% 1M
-5.09 42.18% 6M
-9.24 57.00% YTD
-0.03 0.43% 1Y
+1.13 19.26% 3Y
-7.27 51.04% 5Y
-290.48 97.66% 10Y
Nasdaq, Closing price Tue, May 06 2025
+0.18 2.65%
ISIN
US28531P1030
Symbol
ECOR
Sector

Key metrics

Market capitalization $50.14m
Enterprise Value $42.06m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.67
P/S ratio (TTM) P/S ratio 1.99
P/B ratio (TTM) P/B ratio 6.14
Revenue growth (TTM) Revenue growth 57.09%
Revenue (TTM) Revenue $25.18m
EBIT (operating result TTM) EBIT $-12.16m
Free Cash Flow (TTM) Free Cash Flow $-6.95m
Cash position $12.22m
EPS (TTM) EPS $-1.70
P/E forward negative
P/S forward 1.54
EV/Sales forward 1.29
Short interest 10.78%
Show more

Is electroCore, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,795 stocks worldwide.

electroCore, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a electroCore, Inc. forecast:

4x Buy
100%

Analyst Opinions

4 Analysts have issued a electroCore, Inc. forecast:

Buy
100%

Financial data from electroCore, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
25 25
57% 57%
100%
- Direct Costs 3.79 3.79
35% 35%
15%
21 21
62% 62%
85%
- Selling and Administrative Expenses 30 30
18% 18%
119%
- Research and Development Expense 2.36 2.36
56% 56%
9%
-11 -11
38% 38%
-43%
- Depreciation and Amortization 1.26 1.26
0% 0%
5%
EBIT (Operating Income) EBIT -12 -12
35% 35%
-48%
Net Profit -12 -12
37% 37%
-47%

In millions USD.

Don't miss a Thing! We will send you all news about electroCore, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

electroCore, Inc. Stock News

Neutral
GlobeNewsWire
5 days ago
Addition of Quell® Platform Broadens electroCore's Bioelectronic Technology Portfolio and Accelerates Growth in Chronic Pain and Wellness Markets Addition of Quell® Platform Broadens electroCore's Bioelectronic Technology Portfolio and Accelerates Growth in Chronic Pain and Wellness Markets
Neutral
GlobeNewsWire
6 days ago
ROCKAWAY, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that its flagship wellness product, Truvaga Plus, now works with the Apple® Health app.
Neutral
GlobeNewsWire
7 days ago
ROCKAWAY, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic technology company, announced today that it will report financial results for the first quarter ended March 31, 2025, after the close of the market on Wednesday, May 7, 2025.
More electroCore, Inc. News

Company Profile

electroCore, Inc. is a commercial stage medical device company, which engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The company was founded by Joseph P. Errico, Steven M. Mendez, Peter S. Staats, and Thomas J. Errico in September 2005 and is headquartered in Basking Ridge, NJ.

Head office United States
CEO Daniel Goldberger
Employees 73
Founded 2005
Website www.electrocore.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today